Literature DB >> 32739433

Management of intra-abdominal-infections: 2017 World Society of Emergency Surgery guidelines summary focused on remote areas and low-income nations.

Gennaro Perrone1, Massimo Sartelli2, Giuffrida Mario3, Alain Chichom-Mefire4, Francesco Maria Labricciosa5, Fikri M Abu-Zidan6, Luca Ansaloni7, Walter L Biffl8, Marco Ceresoli7, Federico Coccolini9, Raul Coimbra10, Zaza Demetrashvili11, Salomone Di Saverio12, Gustavo Pereira Fraga13, Vladimir Khokha14, Andrew W Kirkpatrick15, Yoram Kluger16, Ari Leppaniemi17, Ronald V Maier18, Ernest Eugene Moore19, Ionut Negoi20, Carlos A Ordonez21, Boris Sakakushev22, Helmut A Segovia Lohse23, George C Velmahos24, Imtaz Wani25, Dieter G Weber26, Elena Bonati27, Fausto Catena1.   

Abstract

BACKGROUND: Most remote areas have restricted access to healthcare services and are too small and remote to sustain specialist services. In 2017, the World Society of Emergency Surgery (WSES) published guidelines for the management of intra-abdominal infections. Many hospitals, especially those in remote areas, continue to face logistical barriers, leading to an overall poorer adherence to international guidelines.
METHODS: The aim of this paper is to report and amend the 2017 WSES guidelines for the management of intra-abdominal infections, extending these recommendations for remote areas and low-income countries. A literature search of the PubMed/MEDLINE databases was conducted covering the period up until June 2020.
RESULTS: The critical shortages of healthcare workers and material resources in remote areas require the use of a robust triage system. A combination of abdominal signs and symptoms with early warning signs may be used to screen patients needing immediate acute care surgery. A tailored diagnostic step-up approach based on the hospital's resources is recommended. Ultrasound and plain X-ray may be useful diagnostic tools in remote areas. The source of infection should be totally controlled as soon as possible.
CONCLUSIONS: The cornerstones of effective treatment for intra-abdominal infections in remote areas include early diagnosis, prompt resuscitation, early source control, and appropriate antimicrobial therapy. Standardization in applying the guidelines is mandatory to adequately manage intra-abdominal infections.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Acute appendicitis; Acute cholecystitis; Acute diverticulitis; Antimicrobial resistance; Intra-abdominal infections; Remote areas

Year:  2020        PMID: 32739433     DOI: 10.1016/j.ijid.2020.07.046

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

1.  Conservative management of complicated colonic diverticulitis: long-term results.

Authors:  Gennaro Perrone; Mario Giuffrida; Antonio Tarasconi; Gabriele Luciano Petracca; Alfredo Annicchiarico; Elena Bonati; Giorgio Rossi; Fausto Catena
Journal:  Eur J Trauma Emerg Surg       Date:  2022-03-09       Impact factor: 3.693

2.  The Role of Antibiotics in Endoscopic Transmural Drainage of Post-Inflammatory Pancreatic and Peripancreatic Fluid Collections.

Authors:  Mateusz Jagielski; Wojciech Kupczyk; Jacek Piątkowski; Marek Jackowski
Journal:  Front Cell Infect Microbiol       Date:  2022-07-05       Impact factor: 6.073

3.  Open abdomen in the management of complicated diaphragmatic hernia: a case report.

Authors:  Alfredo Annicchiarico; Mario Giuffrida; Paolo Del Rio; Elena Bonati; Gennaro Perrone; Fausto Catena
Journal:  Acta Biomed       Date:  2021-04-30

Review 4.  Percutaneous Endoscopic Necrosectomy-A Review of the Literature.

Authors:  Mateusz Jagielski; Agata Chwarścianek; Jacek Piątkowski; Marek Jackowski
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

5.  Conservative Management of Complicated Colonic Diverticulitis in Early and Late Elderly.

Authors:  Gennaro Perrone; Mario Giuffrida; Elena Bonati; Gabriele Luciano Petracca; Antonio Tarasconi; Gianluca Baiocchi; Fausto Catena
Journal:  Medicina (Kaunas)       Date:  2021-12-24       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.